Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
121.50    -0.50 (-0.41%)
Bid:
120.00
Ask:
122.00
Spread: 2.00 (1.667%)
Market Cap: £95.35m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

16 Jul 2020 07:00

RNS Number : 1439T
Xaar PLC
16 July 2020
 

Xaar plc

 

Trading update 

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology, today announces a trading update for the six months ended 30 June 2020.

 

TRADING

 

The Board is pleased to announce that trading for the six months ending 30 June 2020 has been in line with expectations and good progress has been made implementing our strategy. Revenue for the period is expected to be £23.7m, representing a decline of 7% relative to H1 2019 and in line with H2 2019.

 

The Printhead business continues to perform well as changes in the go to market strategy have seen early successes with several new accounts won and customers re-engaging with the business. The restructuring undertaken in the second half of 2019 has left the business well positioned both to deal with the current economic climate but also to deliver a sustainable and strong business in the longer-term.

 

The Product Print Systems business has been impacted by COVID-19 with annuities and machine sales both below our original plan. Despite that, good progress has been made in embedding the new strategy and driving operational performance with revenue slightly increased relative to the first half of 2019.

 

The 3D business has continued to make good progress. Despite minor delays due to lockdown restrictions, product development and testing is progressing well and investment in the go to market strategy is underway.

 

BALANCE SHEET AND LIQUIDITY

 

The Group retains a strong balance sheet and cash position. Cash and cash equivalents at 30 June 2020 were £23.9m with both the Printhead and Product Print Systems business improving their cash balance relative to 31 December 2019. The 3D business continues to be well positioned to fund its development and go to market needs. The Group maintains a strong cash focus and disciplined cost controls.

 

CURRENT TRADING AND OUTLOOK

 

The Group continues to manage operations in response to the constraints caused by COVID-19 with the priority of safeguarding the health and wellbeing of our employees. Despite these constraints, operations have remained effective and efficient.

 

As a result of the continued uncertainty surrounding economic conditions globally, the Board will not be providing guidance at this time. The short-term order book is healthy, and the business is well placed to withstand the difficult trading environment. The Board remains focused on the medium-term strategy to return the business to profitability and growth and will provide more details on our future plans at the half year results in September.

 

John Mills, Chief Executive Officer, commented:

 

"We are pleased with our performance for the first half which is testament to the new strategy we have in place and all of our staff who have managed the business well during a tough period. It has been particularly pleasing to see success in re-engaging with our core customer base whilst also winning new business.

 

Although short-term uncertainty will remain, the changes we have made enable us to be well positioned for the long-term. The fundamentals remain compelling, the market opportunity remains significant and we are excited about future of the business."

 

 

Enquiries:

 

Xaar plc

Ian Tichias, Chief Finance Officer

& Company Secretary

 

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

Tulchan Communications

 

 

 

+44 (0) 207 353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKELFFBDLFBBB
Date   Source Headline
26th Apr 20215:51 pmRNSHolding(s) in Company
22nd Apr 202112:18 pmRNSDirector Declaration
15th Apr 20212:24 pmRNSNotice of 2020 Preliminary Results
6th Apr 202112:12 pmRNSHolding(s) in Company
1st Apr 20211:50 pmRNSTotal Voting Rights
1st Mar 20215:18 pmRNSTotal Voting Rights
10th Feb 20212:25 pmRNSHolding(s) in Company
1st Feb 202111:01 amRNSTotal Voting Rights
28th Jan 20212:49 pmRNSHolding(s) in Company
21st Jan 202110:27 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSTrading Statement
4th Jan 202111:38 amRNSTotal Voting Rights
1st Dec 20204:43 pmRNSTotal Voting Rights
9th Nov 202010:42 amRNSHolding(s) in Company
4th Nov 202011:00 amRNSUpdate on cyber security incident
3rd Nov 202011:29 amRNSGrant of options under SAYE Scheme
3rd Nov 202011:15 amRNSHolding(s) in Company
2nd Nov 202011:40 amRNSTotal Voting Rights
7th Oct 20207:00 amRNSNotice of cyber security incident
6th Oct 20204:48 pmRNSHolding(s) in Company
1st Oct 202012:59 pmRNSTotal Voting Rights
30th Sep 20207:00 amRNS2020 Interim Results
3rd Sep 20204:24 pmRNSHolding(s) in Company
3rd Sep 20201:20 pmRNSNotice of Interim Results
1st Sep 202010:42 amRNSTotal Voting Rights
5th Aug 202012:47 pmRNSTotal Voting Rights
3rd Aug 20208:59 amRNSChange of Adviser
16th Jul 20207:00 amRNSTrading Statement
9th Jul 20204:36 pmRNSPrice Monitoring Extension
1st Jul 20203:17 pmRNSConfirmation of Board Change & Succession
1st Jul 202011:47 amRNSTotal Voting Rights
5th Jun 20207:00 amRNSGrant of Options
2nd Jun 202011:16 amRNSTotal Voting Rights
2nd Jun 202011:13 amRNSResult of AGM
2nd Jun 20207:00 amRNSTrading Statement
15th May 202010:59 amRNSHolding(s) in Company
7th May 20207:00 amRNSNotice of Annual General Meeting
1st May 20203:10 pmRNSTotal Voting Rights
30th Apr 20202:27 pmRNSHolding(s) in Company
29th Apr 202012:04 pmRNSDisclosure of Rights attached to Equity Shares
29th Apr 202011:41 amRNSGrant of option
28th Apr 20205:27 pmRNSHolding(s) in Company
27th Apr 20202:23 pmRNSHolding(s) in Company
27th Apr 20202:00 pmRNSDirectorate Change - Appointment
24th Apr 20203:10 pmRNSHolding(s) in Company
24th Apr 20203:02 pmRNSAnnual Financial Report
23rd Apr 20202:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSAnnual Financial Report
9th Apr 20209:15 amRNSHolding(s) in Company
6th Apr 20203:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.